A Novel Phenotypic Drug Susceptibility Assay for Human Immunodeficiency Virus Type 1

Christos J. Petropoulos, Neil Parkin, Kay Limoli, +8

Antimicrobial Agents and Chemotherapy

Development and Characterization of a Novel Single-Cycle Recombinant-Virus Assay To Determine Human Immunodeficiency Virus Type 1 Coreceptor Tropism

Jeannette M. Whitcomb, Wei Huang, Signe Fransen, +7

Antimicrobial Agents and Chemotherapy

Primary ImmunodeficiencyNeurovirologyHuman RetrovirusPathogenesisImmunology +12

Discovery and Characterization of Vicriviroc (SCH 417690), a CCR5 Antagonist with Potent Activity against Human Immunodeficiency Virus Type 1

Julie Strizki, Cécile Tremblay, Serena Xu, +15

Antimicrobial Agents and Chemotherapy

Antiviral CompoundNeurovirologyMedicineImmunologyAntiviral Response +13

Coreceptor Tropism in Human Immunodeficiency Virus Type 1 Subtype D: High Prevalence of CXCR4 Tropism and Heterogeneous Composition of Viral Populations

Wei Huang, Susan H. Eshleman, Jonathan Toma, +12

Journal of Virology

Primary ImmunodeficiencyCxcr4 TropismD Hiv-1Viral PopulationsHuman Retrovirus +12

Loss of Raltegravir Susceptibility by Human Immunodeficiency Virus Type 1 Is Conferred via Multiple Nonoverlapping Genetic Pathways

Signe Fransen, Soumi Gupta, Robert M. Danovich, +5

Journal of Virology

Viral ReplicationGeneticsImmunologyHuman RetrovirusResistance Mutation (Virology) +14

Prevalence of CXCR4 Tropism among Antiretroviral‐Treated HIV‐1–Infected Patients with Detectable Viremia

Peter W. Hunt, P. Richard Harrigan, Wei Huang, +10

The Journal of Infectious Diseases

Primary ImmunodeficiencySexual HealthCxcr4 TropismTreatment And PreventionHuman Retrovirus +13

Viral fitness cost prevents HIV-1 from evading dolutegravir drug pressure

Thibault Mésplède, Peter K. Quashie, Nathan Osman, +6

Retrovirology

Selection of HIV Variants with Signature Genotypic Characteristics during Heterosexual Transmission

Manish Sagar, Oliver Laeyendecker, Jordyn Gamiel, +8

The Journal of Infectious Diseases

Treatment of Advanced Human Immunodeficiency Virus Type 1 Disease with the Viral Entry Inhibitor PRO 542

Jeffrey M. Jacobson, Robert J. Israel, Israel Lowy, +13

Antimicrobial Agents and Chemotherapy

Viral Entry InhibitorsHuman RetrovirusImmunologyPharmacologyHiv-1 Disease Progression +11

Inactivation of AMPK alters gene expression and promotes growth of prostate cancer cells

Jing Zhou, Wei Huang, Rong Tao, +8

Oncogene

UrologySignal TransductionSignaling PathwayReceptor Tyrosine KinaseProstate Cancer Cells +6